Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage.

ABSTRACT:

Importance

Intracerebral hemorrhage (ICH) is the deadliest stroke subtype, and mortality rates are especially high in anticoagulation-associated ICH. Recently, specific anticoagulation reversal strategies have been developed, but it is not clear whether there is a time-dependent treatment effect for door-to-treatment (DTT) times in clinical practice.

Objective

To evaluate whether DTT time is associated with outcome among patients with anticoagulation-associated ICH treated with reversal interventions.

Design, setting, and participants

This cohort study used data from the American Heart Association Get With The Guidelines-Stroke quality improvement registry. Patients with ICH who presented within 24 hours of symptom onset across 465 US hospitals from 2015 to 2021 were

SUBMITTER: Sheth KN 

PROVIDER: S-EPMC11002694 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature